Different evidence of key amprenavir resistance mutations on the efficacy of darunavir

AIDS. 2008 Jan 30;22(3):437-8. doi: 10.1097/QAD.0b013e3282f4a0cc.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carbamates / pharmacology
  • Carbamates / therapeutic use*
  • Darunavir
  • Drug Resistance, Viral / genetics*
  • Drug Therapy, Combination
  • Furans
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease Inhibitors / pharmacology
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Humans
  • Mutation*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / therapeutic use
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*
  • Treatment Failure
  • Treatment Outcome

Substances

  • Carbamates
  • Furans
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors
  • Sulfonamides
  • amprenavir
  • Ritonavir
  • Darunavir